Sanofi, Novo, Lilly Look To Ditch Minn. AG's Insulin Suit
By Bryan Koenig · August 13, 2019, 6:28 PM EDT
Sanofi-Aventis U.S. LLC, Novo Nordisk Inc. and Eli Lilly and Co. urged a New Jersey federal judge Monday to toss the Minnesota attorney general's insulin pricing lawsuit against them, arguing that...
To view the full article, register now.